Investigators at Icahn School of Medicine at Mount Sinai Describe Findings in Myelofibrosis (Cross-study Comparisons of Jak2 Inhibitors In Myelofibrosis: Risks and Recommendations)

Press/Media

Period20 Nov 2023

Media coverage

1

Media coverage

  • TitleInvestigators at Icahn School of Medicine at Mount Sinai Describe Findings in Myelofibrosis (Cross-study Comparisons of Jak2 Inhibitors In Myelofibrosis: Risks and Recommendations)
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date20/11/23
    PersonsJohn Mascarenhas